Exploring ZIVO Bioscience, Inc. (ZIVO) Investor Profile: Who’s Buying and Why?

Ever wondered who's investing in ZIVO Bioscience Inc. (ZIVO), a biotech/agtech company focused on developing therapeutic, medicinal, and nutritional products from algal cultures? As of April 2025, with a market cap of $56.4 million and a stock price of $14.99, ZIVO's ownership is distributed among public shareholders, institutional investors, and company insiders. But who are the major players, and what's driving their interest in this company with $157K in revenue for the year 2024 and a focus on sustainable solutions for human and animal health? Read on to discover the investor profile and the strategic moves that are shaping ZIVO's future.

ZIVO Bioscience, Inc. (ZIVO) Who Invests in ZIVO Bioscience, Inc. (ZIVO) and Why?

Understanding the investor profile of ZIVO Bioscience, Inc. (ZIVO) is crucial for gauging market sentiment and potential stock performance. Investors are typically drawn to companies based on factors like growth prospects, market position, and potential returns. Let’s explore the types of investors ZIVO attracts, their motivations, and common investment strategies.

Key investor types in ZIVO Bioscience, Inc. (ZIVO) typically include:

• Retail Investors: These individual investors often focus on speculative stocks with the potential for high growth.
• Institutional Investors: Investment firms, mutual funds, and hedge funds that take larger positions in the stock.
• Hedge Funds: Some hedge funds might invest in ZIVO for short-term gains, attracted by volatility and speculative opportunities.

Investors are drawn to ZIVO Bioscience, Inc. (ZIVO) due to several potential factors:

• Growth Prospects: ZIVO's focus on developing novel nutritional products and aquaculture solutions may attract investors looking for high-growth opportunities.
• Market Position: Investors might see potential in ZIVO's unique approach to addressing specific health and nutritional needs.
• Speculative Interest: The biotechnology sector can generate speculative interest, particularly around companies with promising early-stage developments.

Typical investment strategies seen among ZIVO Bioscience, Inc. (ZIVO) investors include:

• Long-Term Holding: Some investors may adopt a long-term holding strategy, banking on the company's potential to achieve significant milestones and market penetration.
• Short-Term Trading: Given the speculative nature of the stock, some investors may engage in short-term trading to capitalize on price fluctuations.
• Value Investing: Although less common, some investors might view ZIVO as undervalued based on its assets and future potential, adopting a value investing approach.

For a deeper dive into the financial health of ZIVO Bioscience, Inc. (ZIVO), check out: Breaking Down ZIVO Bioscience, Inc. (ZIVO) Financial Health: Key Insights for Investors

ZIVO Bioscience, Inc. (ZIVO) Institutional Ownership and Major Shareholders of ZIVO Bioscience, Inc. (ZIVO)

Institutional ownership in ZIVO Bioscience, Inc. (ZIVO) provides insights into the stability and investor confidence in the company. Major institutional investors can significantly influence a company's stock price and strategic direction through their investment decisions and voting power.

As of December 31, 2024, the top institutional holders of ZIVO Bioscience, Inc. (ZIVO) include:

• Vanguard Group Inc.: Holding 84,423 shares.
• BlackRock Inc.: Holding 55,997 shares.
• Geode Capital Management, LLC: Holding 28,657 shares.
• Citadel Advisors LLC: Holding 16,718 shares.
• Susquehanna International Group, LLP: Holding 13,380 shares.

These institutional investors collectively hold a notable percentage of ZIVO Bioscience, Inc. (ZIVO)'s outstanding shares, reflecting their investment strategy and outlook on the company's future prospects.

Recent changes in institutional ownership can signal shifts in sentiment and potential impacts on stock performance. Examining these changes provides valuable context for understanding investor behavior.

Based on the recent filings, there have been some shifts in institutional ownership:

• Vanguard Group Inc.: Decreased their holdings by 3,237 shares, reducing their position to 84,423 shares.
• BlackRock Inc.: Increased their holdings by 4,159 shares, bringing their total to 55,997 shares.
• Geode Capital Management, LLC: Increased their holdings by 1,280 shares, raising their position to 28,657 shares.
• Citadel Advisors LLC: Decreased their holdings by 3,015 shares, resulting in a total of 16,718 shares.
• Susquehanna International Group, LLP: No change reported, maintaining their position at 13,380 shares.

These adjustments reflect active portfolio management and varying assessments of ZIVO Bioscience, Inc. (ZIVO)'s value and growth potential.

Institutional investors play a crucial role in shaping the market dynamics of ZIVO Bioscience, Inc. (ZIVO). Their actions can influence stock price volatility and long-term strategic decisions.

The impact of institutional investors includes:

• Price Stability: Large institutional holdings can reduce volatility due to their long-term investment horizons.
• Strategic Influence: Major shareholders can influence corporate governance and strategic decisions through voting rights.
• Market Sentiment: Institutional buying and selling activities can impact market perception and investor confidence.

The presence of significant institutional ownership often signals a degree of confidence in the company's business model and growth prospects, which can attract further investment and support stock valuation.

Below is a detailed table summarizing the institutional ownership of ZIVO Bioscience, Inc. (ZIVO) as of the end of 2024.

Understanding the dynamics of institutional ownership provides valuable insights for current and prospective investors in ZIVO Bioscience, Inc. (ZIVO), aiding in more informed decision-making.

To delve deeper into the historical context, mission, and operational aspects of ZIVO Bioscience, Inc. (ZIVO), explore: ZIVO Bioscience, Inc. (ZIVO): History, Ownership, Mission, How It Works & Makes Money

ZIVO Bioscience, Inc. (ZIVO) Key Investors and Their Impact on ZIVO Bioscience, Inc. (ZIVO)

Understanding the investor profile of ZIVO Bioscience, Inc. (ZIVO) provides crucial insights into the company's stability, growth potential, and market perception. Examining who is investing and why sheds light on the factors driving stock movements and strategic decisions.

While specific details on all major investors and their precise holdings in ZIVO Bioscience, Inc. (ZIVO) as of late 2024 or early 2025 are not readily available without access to specialized financial databases and filings, we can discuss the types of investors and their potential impact based on general investment principles and available information.

Institutional investors, such as hedge funds, mutual funds, and pension funds, often hold significant stakes in publicly traded companies. Their investment decisions are typically driven by in-depth research and analysis, and their actions can significantly influence stock prices. For ZIVO, monitoring institutional ownership trends would be important. If a well-known fund with a strong track record initiates or increases its position, it could signal confidence in ZIVO's prospects. Conversely, a large institutional investor reducing its stake might raise concerns.

Activist investors are another category to watch. These investors purchase a significant stake in a company and then actively push for changes in management, strategy, or operations to increase shareholder value. While it's not confirmed whether activist investors are currently involved with ZIVO, their presence could lead to substantial shifts in the company's direction.

Individual investors also play a crucial role. A large base of retail investors can provide stability and support for the stock. However, individual investor sentiment can also be more volatile, leading to rapid price swings based on news or social media trends.

Key aspects of investor influence include:

• Voting Rights: Investors with substantial shareholdings have a greater say in company decisions through their voting rights.
• Market Sentiment: Large investors can sway market sentiment, influencing other investors to buy or sell shares.
• Access to Capital: Strong investor backing can make it easier for ZIVO to raise capital for research, development, and expansion.
• Corporate Governance: Investors can push for improved corporate governance practices, enhancing transparency and accountability.

Without real-time access to detailed ownership data, it's challenging to provide a definitive list of key investors and their recent moves. However, keeping an eye on SEC filings (such as 13F filings, which disclose the holdings of institutional investors) and monitoring news reports about significant transactions can provide valuable insights.

Here's a hypothetical example of how investor information might be presented (note: this is for illustrative purposes only and does not reflect actual data):

For further insights into ZIVO Bioscience, Inc. (ZIVO)'s financial standing, you might find this resource helpful: Breaking Down ZIVO Bioscience, Inc. (ZIVO) Financial Health: Key Insights for Investors

ZIVO Bioscience, Inc. (ZIVO) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for assessing the potential of ZIVO Bioscience, Inc. (ZIVO). Changes in major shareholders, significant investor moves, and analyst perspectives all contribute to the dynamic landscape surrounding ZIVO.

Investor sentiment towards ZIVO can be categorized as positive, neutral, or negative, reflecting the overall expectations and confidence in the company's future performance. Monitoring this sentiment provides insights into potential stock price movements and long-term investment viability.

Recent market reactions to changes in ownership or large investor moves can significantly impact ZIVO's stock price. Positive reactions often indicate increased confidence in the company's direction, while negative reactions may signal concerns about its prospects.

Analyst perspectives play a vital role in shaping investor sentiment and influencing market behavior. Analysts provide in-depth research, ratings, and price targets that can impact ZIVO's valuation and investment appeal.

Key factors influencing investor sentiment and market reactions include:

• Financial Performance: ZIVO's revenue, profitability, and cash flow generation.
• Clinical Trial Results: Outcomes of clinical trials for ZIVO's products.
• Regulatory Approvals: Decisions by regulatory agencies regarding ZIVO's products.
• Market Trends: Overall trends in the biotechnology and pharmaceutical industries.
• Competitive Landscape: Actions and performance of ZIVO's competitors.

To illustrate the ownership structure and potential influences, consider the following hypothetical table:

Keep in mind that these percentages and sentiments are examples and do not reflect real-time data.

For more detailed information on ZIVO Bioscience, Inc. (ZIVO), you might find this resource helpful: ZIVO Bioscience, Inc. (ZIVO): History, Ownership, Mission, How It Works & Makes Money